Literature DB >> 20682174

Actin cytoskeleton participation in the onset of IL-1beta induction of an invasive mesenchymal-like phenotype in epithelial MCF-7 cells.

Janusz Franco-Barraza1, Julio E Valdivia-Silva, Horacio Zamudio-Meza, Aida Castillo, Eduardo A García-Zepeda, Luis Benítez-Bribiesca, Isaura Meza.   

Abstract

BACKGROUND: Interleukin 1 beta (IL-1beta) and other inflammatory cytokines are reported to induce phenotypic changes in epithelial breast cancer tumor cells related to increased invasiveness. Mechanisms involved in the process are not well understood.
METHODS: The noninvasive breast cancer epithelial cell line MCF-7 was used to investigate the IL-1beta-induced phenotype. Live cells expressing EGFP-actin were monitored for cell morphology changes and actin cytoskeleton dynamics by time-lapse video microscopy in the presence of IL-1beta and specific inhibitors of actin signaling pathways. Chemotaxis, invasion of Matrigel, MMP activity and expression of S100A4 in cells treated with IL-1beta were assessed by migration assays, zymograms and immunoblots.
RESULTS: Exposure to IL-1beta specifically induced a change in MCF-7 cells from a typical epithelial morphology into elongated cells, showing numerous dynamic actin-rich lamellae and peripheral ruffles characteristic of fibroblasts. These cells could scatter from compact cell colonies and respond to chemoattractants such as the homing-associated chemokine CXCL-12. Pharmacological blockage of actin signaling pathways and negative mutants of RhoGTPases revealed that actin reorganization and enhanced motility are regulated via PI3K/Rac 1 activation. IL-1beta-stimulated cells expressed the metastasis promoter S100A4, increased secretion of active MMP-9 and MMP-2 and invasion of extracellular matrix proteins.
CONCLUSIONS: IL-1beta induces a PI3K/Rac 1-regulated reorganization of the actin cytoskeleton of MCF-7 cells that is required for cell scattering, elongation and migration. The enhanced motility is accompanied by expression of protein markers correlated with invasive behavior. Copyright 2010 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682174     DOI: 10.1016/j.arcmed.2010.04.010

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  19 in total

Review 1.  Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.

Authors:  Sarah C Baumgarten; Jonna Frasor
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 2.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

3.  Inflammatory factors of the tumor microenvironment induce plasticity in nontransformed breast epithelial cells: EMT, invasion, and collapse of normally organized breast textures.

Authors:  Tal Leibovich-Rivkin; Yulia Liubomirski; Biana Bernstein; Tsipi Meshel; Adit Ben-Baruch
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

4.  Short term exposure of beta cells to low concentrations of interleukin-1β improves insulin secretion through focal adhesion and actin remodeling and regulation of gene expression.

Authors:  Caroline Arous; Pedro G Ferreira; Emmanouil T Dermitzakis; Philippe A Halban
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

5.  Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.

Authors:  Massimiliano Cadamuro; Gaia Spagnuolo; Luisa Sambado; Stefano Indraccolo; Giorgia Nardo; Antonio Rosato; Simone Brivio; Chiara Caslini; Tommaso Stecca; Marco Massani; Nicolò Bassi; Eugenio Novelli; Carlo Spirli; Luca Fabris; Mario Strazzabosco
Journal:  Cancer Res       Date:  2016-06-21       Impact factor: 12.701

6.  Interleukin-1β and tumor necrosis factor-α increase stiffness and impair contractile function of articular chondrocytes.

Authors:  Cheng Chen; Jing Xie; Ravikumar Rajappa; Linhong Deng; Jeffrey Fredberg; Liu Yang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-12-17       Impact factor: 3.848

7.  Selection of a MCF-7 Breast Cancer Cell Subpopulation with High Sensitivity to IL-1β: Characterization of and Correlation between Morphological and Molecular Changes Leading to Increased Invasiveness.

Authors:  Eloy Andres Pérez-Yépez; Jorge-Tonatiuh Ayala-Sumuano; Alicia Maria Reveles-Espinoza; Isaura Meza
Journal:  Int J Breast Cancer       Date:  2012-05-10

Review 8.  Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents.

Authors:  Julio Valdivia-Silva; Jaciel Medina-Tamayo; Eduardo A Garcia-Zepeda
Journal:  Int J Mol Sci       Date:  2015-06-08       Impact factor: 5.923

9.  Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.

Authors:  Jian Huang; Xiuwen Lan; Ting Wang; Hailing Lu; Mengru Cao; Shi Yan; Yue Cui; Dexin Jia; Li Cai; Ying Xing
Journal:  Oncogene       Date:  2019-11-18       Impact factor: 9.867

10.  GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response.

Authors:  Paola De Marco; Rosamaria Lappano; Ernestina Marianna De Francesco; Francesca Cirillo; Marco Pupo; Silvia Avino; Adele Vivacqua; Sergio Abonante; Didier Picard; Marcello Maggiolini
Journal:  Sci Rep       Date:  2016-04-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.